Joint venture with Fresenius Medical Care leverages exclusive access to My Reason® dataset with more than 35,000 patients and ML models to develop targets therapies BOSTON, Aug. 4, 2025 /PRNewswire-PRWeb/ -- Nephronomics, a precision medicine company developing targeted therapies for...
↧